Here’s why Maria Sharapova can’t play tennis for 2 YEARS
Sharapova tested positive for meldonium, a performance enhancing drug (also known as mildronate), at the Australian Open back in January. She had been taking the drug since 2006 for a magnesium deficiency.
If she was taking it for a deficiency, why is it now a problem?
The ITF changed up the rules on banned substances, and she tested positive for the newly banned drug.
The ruling came from an independent three-person tribunal appointed by the ITF after a two-day hearing. She originally faced a four-year suspension, but the panel unanimously agreed it was an unintentional violation. So, instead, they shrunk the sentence down to two years.
The ITF are pretty big on following the rules, but Sharapova has already vowed to appeal the sentence. She said the suspension was "unfairly harsh."
The question is: Will Sharapova be able to come back from a two-year suspension, or is this a career-ender?
Get Kicker in your inbox!
Christina is a freelance writer from a tiny town in Southern Maryland who just can't seem to figure out whether others are being sarcastic or not. She has a degree in business communication, with a focus in writing, from Stevenson University, and has written things for Severna Park Voice, Maryland Film Festival, The Villager, and Hello Giggles. Follow her on twitter @tinaBUFF where she constantly overthinks her tweets, or read her medley of musings at touchinfinity.wordpress.com.